- +603-3310 0819
- [email protected]
Oncode connects clinical diagnostics, diagnostic technologies, bioinformatics and data intelligence, and translational research within one precision medicine pathway.
Built on an established clinical diagnostics foundation, the ecosystem is expanding to support the complete journey from clinical need and scientific discovery to validated technology, actionable insight, and regional deployment.
The value of Oncode’s ecosystem lies not only in its individual capabilities, but in the way they reinforce one another.
Clinical diagnostics is the established foundation of Oncode’s ecosystem. Our experience in oncology, hematology, hereditary cancer, rare disease, liquid biopsy, and related molecular applications provides the real-world context from which our broader technologies are developed.
We support healthcare providers with molecular testing and interpretation that inform diagnosis, treatment selection, risk assessment, disease monitoring, and clinical decision-making. This operating foundation gives Oncode direct insight into the quality, workflow, interpretation, and implementation challenges that determine whether precision medicine succeeds in practice.
Oncode’s diagnostic technology platform translates molecular testing expertise into solutions that can be standardised, transferred, and deployed beyond a single laboratory.
Our work spans assay design, diagnostic kit development, workflow optimisation, analytical and clinical validation, and commercial deployment. By designing around real laboratory and healthcare requirements, we aim to create technologies that are not only scientifically sound, but also practical to implement, quality-controlled, and suitable for regional adoption.
Precision medicine depends on more than generating molecular data. It requires systems that can process, interpret, contextualise, and communicate that data accurately and efficiently.
Oncode develops and integrates bioinformatics pipelines, analytical workflows, reporting infrastructure, laboratory intelligence, and data-driven tools that support clinical diagnostics, research, and scalable healthcare decision-making. The objective is to create an intelligence layer that connects molecular complexity with meaningful action.
Oncode collaborates with healthcare institutions, universities, research organisations, pharmaceutical companies, and biotechnology partners to move promising discoveries toward validation and practical use.
Our translational research capability supports biomarker investigation, genomic research, assay development, clinical validation, technology evaluation, and real-world implementation. By connecting scientific expertise with clinical and commercial pathways, we help reduce the distance between discovery and impact.
Molecular testing, hospital programmes, specialist support, clinical validation, and in-hospital implementation.
Assay development, diagnostic kits, workflow optimisation, validation, technology transfer, and commercialisation.
Bioinformatics pipelines, reporting systems, workflow intelligence, analytics, and AI-enabled applications.
Biomarker research, genomic services, proof-of-concept studies, clinical research, and industry-academic partnerships.
